4.10Open4.10Pre Close0 Volume5 Open Interest13.50Strike Price0.00Turnover0.00%IV-13.89%PremiumJul 26, 2024Expiry Date6.94Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.98Leverage Ratio--Theta--Rho--Eff Leverage--Vega
TG Therapeutics Stock Discussion
$AGBA Group(AGBA.US)$
$TG Therapeutics(TGTX.US)$
The company said fourth quarter loss narrowed to 9 cents a share from 39 cents a year earlier. That's smaller than the 11 cents expected by analysts polled by Capital IQ, according to MT Newswires.
Revenue for the three months ende...
No comment yet